Market Closed -
Other stock markets
|
Pre-market 02:54:45 am | |||
88.17 EUR | +1.47% | 88.25 | +0.09% |
07:45am | Sanofi Reports Positive Results from Phase 3 Trial of Rilzabrutinib for Immune Thrombocytopenia | MT |
07:39am | Sanofi Says Blood-Disorder Drug Meets Key Target in Late-Stage Trial | DJ |
Filters
- Stock Market
- Equities
- SAN Stock
- News Sanofi